drug treatment ( ptu , n = 10 , dose 50-400 mg/day or cbz , n = 6 , dose 5-45 mg/day ) was continued throughout pregnancy and delivery in 16 pregnancies producing 18 infants ( group b ) .
C0033511
ptu
C0032961
pregnancies